top of page

Search

How Is the Treatment of Patients with KRAS G12C-Mutated Advanced NSCLC Evolving? Learn more! 4/11/23

Social Media Coordinator
Mar 24, 2023
0 min read

ree

ree

Recent Posts

NEW Event ~ A first-line treatment option for adults with anemia due to lower-risk MDS ~ 11/13/25 @ Capital Grille

NEW Event ~ A first-line treatment option for adults with anemia due to lower-risk MDS ~ 11/13/25 @ Capital Grille

NEW EVENT! ZEPZELCA in combination with atezolizumab in ES-SCLC ~ Thursday, 11/6/25

NEW EVENT! ZEPZELCA in combination with atezolizumab in ES-SCLC ~ Thursday, 11/6/25

LUNCH & LEARN: Clinical Trial Updates: Hematology and Solid Tumor - TOMORROW, Tuesday 10/7/25 @2pm on ZOOM

LUNCH & LEARN: Clinical Trial Updates: Hematology and Solid Tumor - TOMORROW, Tuesday 10/7/25 @2pm on ZOOM

Comments

bottom of page